Affordable Access

Risk factors for treatment delay in pulmonary tuberculosis in Recife, Brazil

Authors
Publisher
BioMed Central
Publication Date
Source
PMC
Keywords
  • Research Article
Disciplines
  • Medicine

Abstract

1471-2458-5-25.fm ral ss BioMed CentBMC Public Health Open AcceResearch article Risk factors for treatment delay in pulmonary tuberculosis in Recife, Brazil Martinho APS dos Santos1, Maria FPM Albuquerque2, Ricardo AA Ximenes1, Norma LCL Lucena-Silva3, Cynthia Braga*3, Antônio RL Campelo4, Odimariles MS Dantas1, Ulisses R Montarroyos3, Wayner V Souza3, Alexandre M Kawasaki1 and Laura C Rodrigues4 Address: 1Departamento de Medicina Tropical, Universidade Federal de Pernambuco, Brazil, 2Departamento de Medicina Clínica, Universidade Federal de Pernambuco, Brazil, and Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Brazil, 3Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz, Brazil and 4London School of Hygiene and Tropical Medicine, University of London, UK Email: Martinho APS dos Santos - [email protected]; Maria FPM Albuquerque - [email protected]; Ricardo AA Ximenes - [email protected]; Norma LCL Lucena-Silva - [email protected]; Cynthia Braga* - [email protected]; Antônio RL Campelo - [email protected]; Odimariles MS Dantas - [email protected]; Ulisses R Montarroyos - [email protected]; Wayner V Souza - [email protected]; Alexandre M Kawasaki - [email protected]; Laura C Rodrigues - [email protected] * Corresponding author Abstract Background: Tuberculosis is still a great challenge to public health in Brazil and worldwide. Early detection followed by effective therapy is extremely important in controlling the disease. Recent studies have investigated reasons for delays in treatment, but there is no agreed definition of what constitutes an "acceptable" delay. This study investigates factors associated with total delay in treatment of tuberculosis. Methods: A cohort of adult cases of pulmonary tuberculosis diagnosed over a two-year period was studied. Patients were interviewed on entry, reporting the duration of symptoms before the start of treatment, and sputum and

There are no comments yet on this publication. Be the first to share your thoughts.